Presentation TVT 2016 Study Design for the EVOLUT R Low-Risk Trial Presenter: Jeffrey J. Popma June 16, 2016
Presentation TVT 2016 The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet? Presenter: Martin B. Leon June 16, 2016
Presentation SOLACI 2016 Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices Presenter: Martin B. Leon June 10, 2016
News Daily News More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices Shelley Wood June 07, 2016
News Daily News Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis Michael O'Riordan June 07, 2016
News Daily News Evolution of TAVR in Denmark May Have Implications for Other Countries L.A. McKeown June 06, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2016 Shelley Wood May 31, 2016
News Conference News EuroPCR 2016 Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices Michael O'Riordan May 23, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 ‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices Caitlin E. Cox May 17, 2016
News Daily News Italian Registry Cautions Against TAVR in Low-Risk Patients L.A. McKeown May 16, 2016
News Conference News EuroPCR 2016 EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’ Shelley Wood May 16, 2016
News Daily News Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests Todd Neale May 12, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients Todd Neale April 27, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016